Clinical Trial Update: PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pembrolizumab with stereotactic body radiotherapy in metastatic non-small cell lung cancer was terminated, and the trial results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Metastatic Non-small-cell lunG Cancer | Phase 1 | Status: TERMINATED | Results posted: 2026-01-29